Stay updated on UCART19 Dose Escalation Study in B-cell ALL Clinical Trial
Sign up to get notified when there's something new on the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page.

Latest updates to the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page
- Check6 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision from v3.4.0 to v3.4.1 is shown, indicating a minor metadata update on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded a 'Show glossary' option and updated the page footer to Revision: v3.4.0, with minor capitalization and wording tweaks in labels such as QC criteria and No FEAR Act data.SummaryDifference0.2%

- Check56 days agoChange DetectedRevision from v3.3.3 to v3.3.4 is shown in the page footer/site-wide release notes; there is no impact on study content, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check78 days agoChange DetectedA consolidated 'Locations' section has been added that lists the study sites by state, and the previous separate sections for Massachusetts, Pennsylvania, and Texas locations have been removed.SummaryDifference0.4%

Stay in the know with updates to UCART19 Dose Escalation Study in B-cell ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page.